Administration provides support to the basic science, clinical, populafion research, and education missions of the Cancer Center. Administrafive support includes, but is not limited to, the following major activities: ? Grants management administrafion and liaison funcfions with the University of Utah Office of Sponsored Projects ? Space management and oversight of facilifies (including glass wash), maintenance, equipment, and security ? Shared Resources oversight and support regarding policies, recharge center acfivifies, analysis, and audits ? Oversight and control of HCI accounting and budgefing processes, including purchasing and receiving, payroll, accounts payable/receivables, general ledger, equipment inventory, financial reporting, financial policies, analysis, and internal controls ? Administrafive support for the Cancer Center Executive Director and Program Leaders ? General Administrafion, including the Cancer Center Support Grant (CCSG) membership process, retreat planning and organizafion, seminar speakers, meefing scheduling and facilitafion, as well as preparafion of meeting minutes ? Human Resources funcfions, including recruitment and annual investigator review process ? In conjunction with respecfive Senior Directors, provide administrative and financial oversight of the Clinical Trials Office and High Risk Clinics and Registry ? Computer network/phone support, data storage, security, and web services ? Web services, communications, and public affairs, including news of Cancer Center research, discoveries, and pafient care advances ? Evaluafion and strategic planning activities We request $105,397 for support of Center administration effort, 6.6% of the total CCSG budget request.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Salt Lake City
United States
Zip Code
Khorashad, J S; Tantravahi, S K; Yan, D et al. (2016) Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy. Leukemia 30:2275-2279
Flores, Kristina G; Steffen, Laurie E; McLouth, Christopher J et al. (2016) Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. J Genet Couns :
Neklason, Deborah W; VanDerslice, James; Curtin, Karen et al. (2016) Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocr Relat Cancer 23:93-100
(2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 53:800-811
Norton, Maria C; Fauth, Elizabeth; Clark, Christine J et al. (2016) Family member deaths across adulthood predict Alzheimer's disease risk: The Cache County Study. Int J Geriatr Psychiatry 31:256-63
Piccolo, Stephen R; Hoffman, Laura M; Conner, Thomas et al. (2016) Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility. Mol Syst Biol 12:860
Zhu, Judy; Fleming, Aaron M; Orendt, Anita M et al. (2016) pH-Dependent Equilibrium between 5-Guanidinohydantoin and Iminoallantoin Affects Nucleotide Insertion Opposite the DNA Lesion. J Org Chem 81:351-9
Riedl, Jan; Fleming, Aaron M; Burrows, Cynthia J (2016) Sequencing of DNA Lesions Facilitated by Site-Specific Excision via Base Excision Repair DNA Glycosylases Yielding Ligatable Gaps. J Am Chem Soc 138:491-4
Serpico, Victoria; Liepert, Amy E; Boucher, Kenneth et al. (2016) The Effect of Previsit Education in Breast Cancer Patients: A Study of a Shared-decision-making Tool. Am Surg 82:259-65
Camp, Nicola J; Lin, Wei-Yu; Bigelow, Alex et al. (2016) Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Res 76:1916-25

Showing the most recent 10 out of 1049 publications